Rheumatoid arthritis

Defining Difficult‐to‐Treat Rheumatoid Arthritis in Routine Care: Comparative Performance of Published Criteria and Description of Early and Late Difficult‐to‐Treat Rheumatoid Arthritis Phenotypes

Arthritis Care Res (Hoboken)Published Retrospective cohort study

Authors' conclusion

The applications of D2T-RA criteria are not interchangeable and vary widely in patient capture. A two-year threshold anchored to the first initiation of advanced therapy offered a clinically balanced early-late D2T-RA framework.

Study context

Population
Patients with rheumatoid arthritis (RA) initiating their first advanced therapy, Ontario Best Practices Research Initiative registry (mean age 56.0 years; 80.7% female; mean disease duration 8.4 years)
Participants
1,121 patients
Exposure
Four literature-derived adaptations of the EULAR difficult-to-treat RA (D2T-RA) definition
Outcome
Prevalence of D2T-RA by each definition and agreement between definitions
Methodological detailslongitudinal real-world RA registry, comparison of four literature-derived adaptations of the EULAR D2T-RA definition
  • Longitudinal real-world RA registry
  • Comparison of four literature-derived adaptations of the EULAR D2T-RA definition

Main finding

As reported in the abstract

Prevalence of D2T-RA
Fulfilled at least one of four D2T-RA definitions
202 (18%)
Patients meeting all definitions 1 through 3
44%

Observational data: associations, not effects.

Further findings

Early vs late D2T-RA, 2-year threshold anchored to initiation of first advanced therapy · two-year threshold

Approximately

Early D2T-RA
40%
Late D2T-RA
60%

Original publication

Defining Difficult‐to‐Treat Rheumatoid Arthritis in Routine Care: Comparative Performance of Published Criteria and Description of Early and Late Difficult‐to‐Treat Rheumatoid Arthritis Phenotypes. Arthritis Care Res (Hoboken). Published 15 September 2026. doi:10.1002/acr.80161

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.